首页> 外文期刊>Cell biochemistry and biophysics >Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease
【24h】

Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease

机译:线粒体自噬:神经退行性疾病的有希望的治疗目标。

获取原文
获取原文并翻译 | 示例
           

摘要

The autophagic process is the only known mechanism for mitochondrial turnover and it has been speculated that dysfunction of autophagy may result in mitochondrial error and cellular stress. Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is associated with cellular oxidative stress and its impact on neurodegeneration. This impaired autophagic function may be considered as a possible mechanism in the pathogenesis of several neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington disease. It can be suggested that autophagy dysfunction along with oxidative stress is considered main events in neurodegenerative disorders. New therapeutic approaches have now begun to target mitochondria as a potential drug target. This review discusses evidence supporting the notion that oxidative stress and autophagy are intimately associated with neurodegenerative disease pathogenesis. This review also explores new approaches that can prevent mitochondrial dysfunction, improve neurodegenerative etiology, and also offer possible cures to the aforementioned neurodegenerative diseases.
机译:自噬过程是线粒体更新的唯一已知机制,据推测自噬功能障碍可能导致线粒体错误和细胞应激。新兴的研究提供了关于线粒体自噬(也称为线粒体吞噬)与细胞氧化应激及其对神经退行性改变的关系的新认识。这种自噬功能受损可能被认为是几种神经退行性疾病的发病机制中的一种可能机制,包括帕金森氏病,阿尔茨海默氏病,多发性硬化症,肌萎缩性侧索硬化症和亨廷顿病。可以认为自噬功能障碍和氧化应激被认为是神经退行性疾病的主要事件。现在,新的治疗方法已开始将线粒体作为潜在的药物靶标。这篇综述讨论了支持氧化应激和自噬与神经退行性疾病发病机制密切相关的观点的证据。这篇综述还探讨了可以预防线粒体功能障碍,改善神经退行性病因的新方法,并为上述神经退行性疾病提供了可能的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号